Physician
Ajay Narwani MD PLLC
Ajay Narwani MD PLLC was paid $4.89M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoAJAY NARWANI MD PLLC
GILBERT, AZ 85233
GILBERT, AZ 85233
33aNPI1275736829assigned 06/08/2007
33bProvider typeAnesthesiology Physician
28Total paid$4.89M
24GClaims128,897
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Arizona
Rank by total paid#7 of 153
Median peer was paid$17K
This provider vs. median288×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,232 | $832K | |
| 2019 | 20,999 | $758K | |
| 2020 | 15,250 | $678K | |
| 2021 | 14,116 | $690K | |
| 2022 | 18,296 | $649K | |
| 2023 | 17,367 | $616K | |
| 2024incomplete | 14,637 | $667K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 27,664 | 24,344 | $1.41M |
| 20553 | 13% | 17,611 | 13,820 | $649K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 16,979 | 15,548 | $632K |
| 64483 | 9.6% | 4,533 | 3,527 | $472K | |
| 64635 | 4.9% | 1,795 | 1,412 | $238K | |
| 64484 | 4.0% | 4,103 | 3,200 | $197K | |
| 64493 | 3.4% | 2,083 | 1,622 | $169K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 2,333 | 2,238 | $138K |
| 64636 | 2.8% | 1,778 | 1,408 | $135K | |
| 20611 | 2.6% | 2,079 | 1,256 | $125K | |
| 64495 | 2.0% | 2,091 | 1,588 | $99K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 2.0% | 584 | 547 | $97K |
33 more codes
| 64494 | 1.9% | 2,040 | $93K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.8% | 720 | $90K |
| 62321 | 1.6% | 1,004 | $79K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,119 | $34K |
| 76881 | <1% | 339 | $30K | |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | <1% | 60 | $29K |
| 97164 | <1% | 900 | $28K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,118 | $20K |
| 64490 | <1% | 206 | $20K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,120 | $19K |
| 64633 | <1% | 107 | $16K | |
| 64491 | <1% | 219 | $12K | |
| 64492 | <1% | 195 | $11K | |
| 97162 | <1% | 206 | $11K | |
| 64634 | <1% | 104 | $10K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 230 | $8K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12,523 | $5K |
| J3490 | Unclassified drugs | <1% | 1,108 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 58 | $4K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,039 | $4K |
| 99000 | <1% | 986 | $1K | |
| A4930 | Gloves, sterile, per pair | <1% | 2,558 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 35 | $835.67 |
| 99490 | Ccm add 20min | <1% | 103 | $371.43 |
| 96138 | <1% | 29 | $322.60 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 34 | $82.38 |
| A4215 | Needle, sterile, any size, each | <1% | 2,966 | $57.72 |
| A4248 | Chlorhexidine containing antiseptic, 1 ml | <1% | 534 | $39.04 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 9,894 | $7.78 |
| 3008F | 0% | 2,317 | $0.00 | |
| 99070 | 0% | 491 | $0.00 | |
| A4550 | Surgical trays | 0% | 850 | $0.00 |
| 0521F | 0% | 52 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNARWANI, AJAY (PAIN MANAGEMENT DOCTOR/PROVIDER)